High Grade Vulvar Squamous Intraepithelial Lesion

High Grade Vulvar Squamous Intraepithelial Lesion — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06075264	Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)(ART-VIN IIB)	recruiting	Phase 2	27	Frantz Viral Therapeutics, LLCINDUSTRY	1	Aug 14, 2025	clinicaltrials
NCT04422366	Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females	recruiting	Phase 3	8,000	Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY	1	Jun 7, 2024	clinicaltrials

Data updated 22 days agoSource updated Aug 14, 2025source: clinicaltrials